Clinical trial

The Effectiveness of Epidermal Growth Factor Serum for the Improvement of Facial Skin Hydration, Elasticity, Pigmentation, and Wrinkles at the Institute of Dermatology: a Single-centered Pilot Study With a One-group Before-and-after Design

Name
008/2565
Description
EGF is a polypeptide that promotes cell differentiation and collagen production while decreasing melanin production. This study is designed to study its effectiveness in improving the texture and appearance of facial skin after daily topical application. We hypothesized that EGF would improve facial skin hydration, elasticity, pigmentation, and wrinkles.
Trial arms
Trial start
2023-01-30
Estimated PCD
2024-01-05
Trial end
2024-01-12
Status
Active (not recruiting)
Treatment
Epidermal Growth Factor
Apply facial twice daily.
Arms:
Epidermal Growth Factor Serum Application
Other names:
Epidermal Growth Factor Serum
Size
30
Primary endpoint
Facial skin hydration
4 months
Transepidermal water loss
4 months
Facial skin elasticity
4 months
Facial skin wrinkles
4 months
Facial skin pigmentation
4 months
Overall facial skin photograph
4 months
Eligibility criteria
Inclusion Criteria: * Thai * Mild to moderate facial skin condition, as measured by 1-2 points on the hyperpigmentation status scale or 2-3 points on the wrinkle severity grading scale. Exclusion Criteria: * Use of lotions or skin care products containing ingredients such as vitamin A/C, hydroquinone, or anti-aging agents. * Sunbathing * Hypersensitivity to serum components * Pregnancy and breast-feeding * Active skin diseases such as eczema or atopic dermatitis at the application site
Protocol
{'studyType': 'INTERVENTIONAL', 'phases': ['NA'], 'designInfo': {'allocation': 'NA', 'interventionModel': 'SINGLE_GROUP', 'primaryPurpose': 'TREATMENT', 'maskingInfo': {'masking': 'NONE'}}, 'enrollmentInfo': {'count': 30, 'type': 'ESTIMATED'}}
Updated at
2024-01-09

1 organization

1 product

1 indication

Indication
Aging